iiinova — where your digital self keeps evolving

IvanVogelius

@ivanvogelius.bsky.social

171 followers 76 following 7 posts

Professor and head of medical physics, dept of Oncology, Rigshospitalet, Denmark

Posts Replies Media

IvanVogelius @ivanvogelius.bsky.social · 19/01/2025

www.linkedin.com/posts/ivan-r...

linkedin.com

Ivan Richter Vogelius on LinkedIn: Very proud of this collaborative work from our teams at Rigshospitalet…

Very proud of this collaborative work from our teams at Rigshospitalet and Herlev og Gentofte Hospital . Very well done and thanks for the effort to all…

040

Reposted by IvanVogelius

Matthias Guckenberger @mguckenberger.bsky.social · 15/12/2024

Remember the misleading press about "brutal" #radonc after PROSPECT ? This is what modern RT can achieve for elderly breast cancer patients ! 👉 "Endocrine Tx was associated with a greater reduction in HRQOL compared with RT at 24 mo" 👉 oncological data awaited www.thelancet.com/journals/lan...

1156

Reposted by IvanVogelius

Matthias Guckenberger @mguckenberger.bsky.social · 05/12/2024

In case you may have missed any of the Virtual Grand Rounds in Radiation Oncology lectures Recordings are 👇 youtube.com/playlist?lis... Endorsed by: ESTRO DEGRO SASRO

1248

Reposted by IvanVogelius

The OncoAlert Network 🚨 @oncoalert.bsky.social · 06/12/2024

Welcome to BlueSky @nejm.org

1236

Reposted by IvanVogelius

Ane Appelt @cancerphysicist.bsky.social · 04/12/2024

Four brilliant days in Vienna - with a super engaged multidisciplinary group of participant 🤩 #radonc #medphys I had a few hours tonight to enjoy the Viennese Christmas markets, and now on a (delayed …) night train towards Brussel @ivanvogelius.bsky.social @cdfuller.bsky.social

2103

Reposted by IvanVogelius

Bluesky @bsky.app · 03/12/2024

Scientists, academics, researchers: We’re excited to share that @altmetric.com is now tracking mentions of your research on Bluesky! 🧪

456294874996

Reposted by IvanVogelius

Maarten van Smeden @maartenvsmeden.bsky.social · 02/12/2024

Introducing the new "NOPE" algorithm This algorithm will tell you "no" all the time. It has been shown to be up to 95% accurate in situations with a prevalence of 5% and *what is even better* even *more accurate* in rarer diseases

310220

IvanVogelius @ivanvogelius.bsky.social · 02/12/2024

Getting ready for day two of ESTRO quantitative methods course. Fantastic group and engaged faculty. Here @cdfuller.bsky.social as a force of nature on “data sharing how and why”

181

Reposted by IvanVogelius

Matthias Guckenberger @mguckenberger.bsky.social · 28/11/2024

Virtual Grand Rounds in Radiation Oncology „Revving Up Gastric Cancer Care: Insights from the TOPGEAR Trial” Presented by Prof. Karin Haustermans December 4th 17:00 – 17:30 Link to online meeting 👇 www.usz.ch/veranstaltun... Endorsed by: ESTRO DEGRO SASRO

093

IvanVogelius @ivanvogelius.bsky.social · 29/11/2024

99 of 100 patients included this week... Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the Liver clinicaltrials.gov/study/NCT036...

clinicaltrials.gov

ClinicalTrials.gov

220

IvanVogelius @ivanvogelius.bsky.social · 23/11/2024

www.thelancet.com/journals/lan...

thelancet.com

Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design

Combining radiotherapy with standard of care plus abiraterone improves radiographic progression-free survival and castration resistance-free survival, but not overall survival in patients with low-vol...

020

IvanVogelius @ivanvogelius.bsky.social · 19/11/2024

First real post: #job We are hiring: We have an open position for a medical physicist. See the job posting here and apply through the portal: www.regionh.dk/job/s%C3%B8g... Important dates: deadline for applications 12/12 2024, interviews Jan 6-9

regionh.dk

010

IvanVogelius @ivanvogelius.bsky.social · 19/11/2024

Happy to join Bluesky. Let’s see what this brings. I hope to use it for a solid human curated interaction on news in radiotherapy and oncology. Like twitter used to be, just better :-)

010